Pharamacology Questions
Pharamacology Questions
Q 5 . Discuss drugs used in pernicious , describe mode of action of any one drug?
Pernicious anemia is a condition where the body cannot absorb enough vitamin B12, leading to anemia and other
complications. The drugs used to treat pernicious anemia are:
H2 blockers (e.g., ranitidine, famotidine) are used to reduce acid production in the stomach.
Adverse effects of H2 blockers:
Q 7 . Write the groups of protein synthesis inhibitors , write four adverse effects of aminoglycosides ?
Protein synthesis inhibitors are a group of antibiotics that work by interfering with protein synthesis in bacteria. They are
classified into two main groups:
1. Bacteriostatic agents:
- Tetracyclines (e.g., doxycycline, minocycline)
- Macrolides (e.g., erythromycin, azithromycin)
- Lincosamides (e.g., clindamycin)
2. Bactericidal agents:
- Aminoglycosides (e.g., gentamicin, tobramycin, amikacin)
- Streptogramins (e.g., quinupristin-dalfopristin)
Aminoglycosides are a group of bactericidal antibiotics that work by binding to the bacterial ribosome and interfering
with protein synthesis.
Adverse effects of Aminoglycosides:
1. Ototoxicity: Aminoglycosides can cause irreversible damage to the inner ear, leading to hearing loss, tinnitus, and
balance problems.
2. Nephrotoxicity: Aminoglycosides can cause kidney damage and acute kidney injury, especially in patients with pre-
existing kidney disease.
3. Neuromuscular blockade: Aminoglycosides can cause muscle weakness and paralysis, especially in patients with
neuromuscular disorders such as myasthenia gravis.
4. Allergic reactions: Aminoglycosides can cause severe allergic reactions, including anaphylaxis, which can be life-
threatening.
The term "bio-availability" refers to the extent to which a drug or substance becomes available to the body after
administration.
"Bio-transformation" is another term for metabolism, which is the process by which the body converts a drug or
substance into a different form. So, bio-transformation is the process that affects bio-availability.
Here are some common reactions of bio-transformation:
1. Oxidation: 2. Reduction:
- Hydroxylation (addition of OH group) - Hydrogenation (addition of hydrogen)
- S-oxidation (oxidation of sulfur-containing compounds) - Reduction of nitro groups (-NO2)
-3. Hydrolysis: 4. Conjugation:
- Ester hydrolysis (breakdown of ester bonds) - Glucuronidation (addition of glucuronic acid)
- Amide hydrolysis (breakdown of amide bonds) - Sulfation (addition of sulfuric acid)
5. Isomerization: 6. Other reactions:
- Stereoisomerization (change in spatial arrangement) - Deamination (removal of amino group)
- Tautomerization (change in functional group) - Dehalogenation (removal of halogen atoms)
- Decarboxylation (removal of carboxyl group)
- Loperamide: slows down the movement of the gut to reduce the number of bowel movements
- Diphenoxylate: slows down bowel movement to reduce the frequency of diarrhea
- Cholestyramine: normalizes the amount of bile acids in the body to prevent diarrhea
- Codeine: relieves pain and prevents diarrhea
- Bismuth subsalicylate: coats irritated tissues in the stomach and intestines to reduce inflammation
- Octreotide: antidiarrheal for those with cancer-induced diarrhea
- Crofelemer: antidiarrheal for HIV/AIDs patients
- Psyllium: regulates bowel movements
- Rifaximin: antidiarrheal for those with irritable bowel syndrome
Group 3: Immunotherapies
Q 10 . Write three groups of anticancer drugs with examples?
These drugs stimulate
Here are three groups of anticancer drugs with examples:
Group 1: Cytotoxic Agents
the immune system to
- These drugs kill cancer cells by damaging their DNA or disrupting cell division. attack cancer cells.
- Examples: - Examples: -
Checkpoint inhibitors
- Alkylating agents (e.g., cyclophosphamide, chlorambucil)
(e.g., pembrolizumab,
- Antimetabolites (e.g., 5-fluorouracil, methotrexate)
nivolumab)-
- Plant alkaloids (e.g., vinblastine, vincristine)
Cancer vaccines
Group 2: Targeted Therapies
(e.g., sipuleucel-T,
These drugs target specific molecules involved in cancer cell growth and
CimaVax-EGF)
survival.
Adoptive T-cell therapies
- Examples:
(e.g., CAR-T cell therapy
- Tyrosine kinase inhibitors (e.g., imatinib, trastuzumab)
- Monoclonal antibodies (e.g., rituximab, bevacizumab)
- mTOR inhibitors (e.g., everolimus, temsirolimus)